Clinical Trial Update: Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial is evaluating long-term, high-dose stimulant therapy for methamphetamine use disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Unspecified stimulant

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Methamphetamine Abuse, Methamphetamine-dependence | Phase 2 | Status: RECRUITING